A citation-based method for searching scientific literature

Pál Pacher, Sándor Bátkai, George Kunos. Pharmacol Rev 2006
Times Cited: 1403







List of co-cited articles
970 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



An Introduction to the Endogenous Cannabinoid System.
Hui-Chen Lu, Ken Mackie. Biol Psychiatry 2016
472
15

Isolation and structure of a brain constituent that binds to the cannabinoid receptor.
W A Devane, L Hanus, A Breuer, R G Pertwee, L A Stevenson, G Griffin, D Gibson, A Mandelbaum, A Etinger, R Mechoulam. Science 1992
15

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors.
A C Howlett, F Barth, T I Bonner, G Cabral, P Casellas, W A Devane, C C Felder, M Herkenham, K Mackie, B R Martin,[...]. Pharmacol Rev 2002
13

Structure of a cannabinoid receptor and functional expression of the cloned cDNA.
L A Matsuda, S J Lolait, M J Brownstein, A C Young, T I Bonner. Nature 1990
13


Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations.
S Galiègue, S Mary, J Marchand, D Dussossoy, D Carrière, P Carayon, M Bouaboula, D Shire, G Le Fur, P Casellas. Eur J Biochem 1995
13

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂.
R G Pertwee, A C Howlett, M E Abood, S P H Alexander, V Di Marzo, M R Elphick, P J Greasley, H S Hansen, G Kunos, K Mackie,[...]. Pharmacol Rev 2010
12

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.
R Mechoulam, S Ben-Shabat, L Hanus, M Ligumsky, N E Kaminski, A R Schatz, A Gopher, S Almog, B R Martin, D R Compton. Biochem Pharmacol 1995
10




Endocannabinoid signaling and synaptic function.
Pablo E Castillo, Thomas J Younts, Andrés E Chávez, Yuki Hashimotodani. Neuron 2012
589
8

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain.
T Sugiura, S Kondo, A Sukagawa, S Nakane, A Shinoda, K Itoh, A Yamashita, K Waku. Biochem Biophys Res Commun 1995
8

Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.
Penny F Whiting, Robert F Wolff, Sohan Deshpande, Marcello Di Nisio, Steven Duffy, Adrian V Hernandez, J Christiaan Keurentjes, Shona Lang, Kate Misso, Steve Ryder,[...]. JAMA 2015
8

The emerging role of the endocannabinoid system in endocrine regulation and energy balance.
Uberto Pagotto, Giovanni Marsicano, Daniela Cota, Beat Lutz, Renato Pasquali. Endocr Rev 2006
593
8

Endocannabinoid signaling at the periphery: 50 years after THC.
Mauro Maccarrone, Itai Bab, Tamás Bíró, Guy A Cabral, Sudhansu K Dey, Vincenzo Di Marzo, Justin C Konje, George Kunos, Raphael Mechoulam, Pal Pacher,[...]. Trends Pharmacol Sci 2015
395
8



The endocannabinoid system and its therapeutic exploitation.
Vincenzo Di Marzo, Maurizio Bifulco, Luciano De Petrocellis. Nat Rev Drug Discov 2004
725
7

Cannabinoid CB1 and CB2 Receptor Signaling and Bias.
Mikkel Søes Ibsen, Mark Connor, Michelle Glass. Cannabis Cannabinoid Res 2017
116
7

Targeting the endocannabinoid system: to enhance or reduce?
Vincenzo Di Marzo. Nat Rev Drug Discov 2008
617
7

Cannabinoid signalling.
Dirk G Demuth, Areles Molleman. Life Sci 2006
303
7

Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials.
Robin Christensen, Pernelle Kruse Kristensen, Else Marie Bartels, Henning Bliddal, Arne Astrup. Lancet 2007
724
6

Cannabinoid CB2 receptors: immunohistochemical localization in rat brain.
Jian-Ping Gong, Emmanuel S Onaivi, Hiroki Ishiguro, Qing-Rong Liu, Patricia A Tagliaferro, Alicia Brusco, George R Uhl. Brain Res 2006
581
6

Determination and characterization of a cannabinoid receptor in rat brain.
W A Devane, F A Dysarz, M R Johnson, L S Melvin, A C Howlett. Mol Pharmacol 1988
6

Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly.
Pal Pacher, Sabine Steffens, György Haskó, Thomas H Schindler, George Kunos. Nat Rev Cardiol 2018
191
6

Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor.
R B Laprairie, A M Bagher, M E M Kelly, E M Denovan-Wright. Br J Pharmacol 2015
521
6

Endocannabinoid-mediated control of synaptic transmission.
Masanobu Kano, Takako Ohno-Shosaku, Yuki Hashimotodani, Motokazu Uchigashima, Masahiko Watanabe. Physiol Rev 2009
990
6

A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol.
Jacqueline L Blankman, Gabriel M Simon, Benjamin F Cravatt. Chem Biol 2007
795
6


Endocannabinoid signaling in the brain.
Rachel I Wilson, Roger A Nicoll. Science 2002
898
5

The CB2 receptor and its role as a regulator of inflammation.
Caroline Turcotte, Marie-Renée Blanchet, Michel Laviolette, Nicolas Flamand. Cell Mol Life Sci 2016
242
5

Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus.
A Vanessa Stempel, Alexander Stumpf, Hai-Ying Zhang, Tuğba Özdoğan, Ulrike Pannasch, Anne-Kathrin Theis, David-Marian Otte, Alexandra Wojtalla, Ildikó Rácz, Alexey Ponomarenko,[...]. Neuron 2016
179
5


Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity.
Douglas Osei-Hyiaman, Michael DePetrillo, Pál Pacher, Jie Liu, Svetlana Radaeva, Sándor Bátkai, Judith Harvey-White, Ken Mackie, László Offertáler, Lei Wang,[...]. J Clin Invest 2005
785
5

Cannabinoid receptors and pain.
R G Pertwee. Prog Neurobiol 2001
528
5

An update on PPAR activation by cannabinoids.
Saoirse Elizabeth O'Sullivan. Br J Pharmacol 2016
234
5

Cannabinoid Ligands Targeting TRP Channels.
Chanté Muller, Paula Morales, Patricia H Reggio. Front Mol Neurosci 2019
223
5

Beta-caryophyllene is a dietary cannabinoid.
Jürg Gertsch, Marco Leonti, Stefan Raduner, Ildiko Racz, Jian-Zhong Chen, Xiang-Qun Xie, Karl-Heinz Altmann, Meliha Karsak, Andreas Zimmer. Proc Natl Acad Sci U S A 2008
428
5

Brain cannabinoid receptor 2: expression, function and modulation.
De-Jie Chen, Ming Gao, Fen-Fei Gao, Quan-Xi Su, Jie Wu. Acta Pharmacol Sin 2017
97
5

Cannabinoid receptors as therapeutic targets.
Ken Mackie. Annu Rev Pharmacol Toxicol 2006
336
5

The endocannabinoid system: an overview.
Natalia Battista, Monia Di Tommaso, Monica Bari, Mauro Maccarrone. Front Behav Neurosci 2012
105
5

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides.
B F Cravatt, D K Giang, S P Mayfield, D L Boger, R A Lerner, N B Gilula. Nature 1996
5

Endocannabinoids: synthesis and degradation.
V Di Marzo. Rev Physiol Biochem Pharmacol 2008
236
5

Cannabinoid Delivery Systems for Pain and Inflammation Treatment.
Natascia Bruni, Carlo Della Pepa, Simonetta Oliaro-Bosso, Enrica Pessione, Daniela Gastaldi, Franco Dosio. Molecules 2018
111
5

Review of the Endocannabinoid System.
Hui-Chen Lu, Ken Mackie. Biol Psychiatry Cogn Neurosci Neuroimaging 2021
66
7

Pharmacology of Medical Cannabis.
Md Ruhul Amin, Declan W Ali. Adv Exp Med Biol 2019
72
6


Cannabis sativa: The Plant of the Thousand and One Molecules.
Christelle M Andre, Jean-Francois Hausman, Gea Guerriero. Front Plant Sci 2016
465
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.